Sentinal4D Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.23M
- Investors
-
7
Sentinal4D General Information
Description
Developer of a biotechnology platform designed to advance 3D (three-dimensional) cell-based drug screening and improve understanding of how drugs affect cellular behavior. The company offers unique 3D and 4D (four-dimensional) cellular datasets and AI (artificial intelligence) software that analyses the shape and structure of single cells in three dimensions, enabling pharmaceutical partners to understand drug mechanisms, detect off-target effects, and prioritise promising therapies earlier in development, enabling patients with cancer, neurodegenerative diseases, and chronic inflammatory syndromes to receive personalized therapeutics.
Contact Information
Website
www.sentinal4d.comCorporate Office
- 221 Pentonville Road
- London N1 9UZ
- England, United Kingdom
Corporate Office
- 221 Pentonville Road
- London N1 9UZ
- England, United Kingdom
Sentinal4D Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 14-Jan-2025 | $1.23M | Completed | Startup | ||
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup |
Sentinal4D Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary |
Sentinal4D Comparisons
Industry
Financing
Details
Sentinal4D Competitors (6)
One of Sentinal4D’s 6 competitors is insitro, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| insitro | Venture Capital-Backed | South San Francisco, CA | ||||
| Phenomic AI | Venture Capital-Backed | Toronto, Canada | ||||
| Owkin | Venture Capital-Backed | Paris, France | ||||
| Recursion Pharmaceuticals | Formerly VC-backed | Salt Lake City, UT | ||||
| Alpenglow Biosciences | Venture Capital-Backed | Seattle, WA |
Sentinal4D Signals
Sentinal4D Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arben Ventures | Venture Capital | Minority | ||
| Twin Path Ventures | Venture Capital | Minority | ||
| Cancer Research Technology | Venture Capital | Minority | ||
| Cancer Tech Accelerator | Accelerator/Incubator | Minority | ||
| Capital Research UK | Other | Minority |
Sentinal4D FAQs
-
When was Sentinal4D founded?
Sentinal4D was founded in 2024.
-
Where is Sentinal4D headquartered?
Sentinal4D is headquartered in London, United Kingdom.
-
What is the size of Sentinal4D?
Sentinal4D has 7 total employees.
-
What industry is Sentinal4D in?
Sentinal4D’s primary industry is Drug Discovery.
-
Is Sentinal4D a private or public company?
Sentinal4D is a Private company.
-
What is the current valuation of Sentinal4D?
The current valuation of Sentinal4D is .
-
What is Sentinal4D’s current revenue?
The current revenue for Sentinal4D is .
-
How much funding has Sentinal4D raised over time?
Sentinal4D has raised $1.32M.
-
Who are Sentinal4D’s investors?
Arben Ventures, Twin Path Ventures, Cancer Research Technology, Cancer Tech Accelerator, and Capital Research UK are 5 of 7 investors who have invested in Sentinal4D.
-
Who are Sentinal4D’s competitors?
insitro, Phenomic AI, Owkin, Recursion Pharmaceuticals, and Alpenglow Biosciences are some of the 6 competitors of Sentinal4D.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process